Matritech’s NMP179 for Detection of Cervical Cancer
May 10, 2004 by admin · Leave a Comment
On May 10, 2004 Matritech announced the beginning of clinical testing of 10,000 samples by Sysmex Corporation using NMP179 for the detection of women at risk of or with cervical cancer. The company reported that this novel strategy uses both Sysmex’s flow cytometry technology and Matritech’s NMP179 protein biomarker to perform rapid, cell-by-cell analysis for [...]